Ignite Creation Date:
2024-05-06 @ 3:42 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02352103
Status:
COMPLETED
Last Update Posted:
2022-02-25
First Post:
2015-01-22
Brief Title:
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Study Overview
Official Title:
The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy RARP each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique
Detailed Description:
Traditionally RARP is performed using a trans-peritoneal technique that pass anteriorly to the bladder This technique necessitates the dissection andor manipulation of many structures which might compromise post-operative urinary continence recovery These structures include the pubo-prostatic ligament Santorini plexus neurovascular bundle and veil of Aphrodite Recently a Retzius-sparing technique to perform RARP has beed described This approach passes posteriorly to the bladder through the space of Douglas which should minimize the damaged to the aforementioned structure Theoretically the latter technique should improve post-operative urinary continence recovery However a randomized comparison between the traditional RARP and Retzius-sparing RARP is still lacking
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None